mBio (Feb 2021)

Human Herpesvirus 6B U26 Inhibits the Activation of the RLR/MAVS Signaling Pathway

  • Xuefeng Jiang,
  • Tian Tang,
  • Jinfeng Guo,
  • Yuhang Wang,
  • Peipei Li,
  • Xiangjun Chen,
  • Lily Wang,
  • Yiqun Wen,
  • Junli Jia,
  • Garbarino Emanuela,
  • Benshun Hu,
  • Shuhua Chen,
  • Kun Yao,
  • Linyun Li,
  • Huaming Tang

DOI
https://doi.org/10.1128/mBio.03505-20
Journal volume & issue
Vol. 12, no. 1

Abstract

Read online

HHV-6B (human herpesvirus 6B) is well known to evade host antiviral responses and establish a lifelong latent infection. How HHV-6B evades RNA recognition is still poorly understood. Our results indicate that HHV-6 U26 plays a vital role in RLR/MAVS signaling pathway activity. Knockout of endogenous MAVS could facilitate HHV-6B replication. The findings in this study could provide new insights into host-virus interactions and help develop a new therapy against HHV-6B infection.